News
Jefferies lowered the firm’s price target on Agilent (A) to $116 from $135 and keeps a Hold rating on the shares after having hosted a call ...
The PD-L1 IHC 22C3 PharmDx (Code SK006) assay is now certified for use to aid treatment decisions for patients with gastric or gastroesophageal junction adenocarcinoma.
Agilent (A) announced its PD-L1 IHC 22C3 pharmDx assay has received European IVDR certification for the use as a Companion Diagnostic to aid in ...
Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results